SWOT Analysis
- S
- W
- O
- T
Technical Analysis
Moving Averages
We appreciate your patience. Your content is on the way.
Current Price
- Bullish Moving Averages
- Bearish Moving Averages
Resistance and support
We appreciate your patience. Your content is on the way.
Company Financials
- Profit and loss statement
- Balance sheet
- Quarterly Result
- Ratio
We appreciate your patience. Your content is on the way.
Quick Results Snapshot
We appreciate your patience. Your content is on the way.
Stocks Comparison
Table
Chart
We appreciate your patience. Your content is on the way.
Corporate Action
- Announcement
- Board Meeting
- Dividend
- Split
- Rights
- Events
Insider & Institutional Activity
- Bulk Block Deals
- Insider Trading & SAST
We appreciate your patience. Your content is on the way.
About Vilin Bio Med Ltd
Stock PE (TTM)
Promoter Holding
Book Value
ROCE
ROE
Vilin Bio Med Limited was originally incorporated on June 29, 2005, which commenced business on July 11, 2005 issued by Registrar of Companies, Andhra Pradesh, Hyderabad. The Company started its first commercial production in 2006. In 2007, the Company expanded the Phase 2 for Beta Lactum facility with 16000 sft for Tablet, Capsule and Dry Syrup sections. In 2010, it acquired more than 1000 molecules Drug Approvals with different strengths in therapeutics of Diabetic, Neuro and Cardio. The Company added the Sachet section in Non-Beta Lactum facility in 2014. The Company allotted a fresh issue of 40,00,000 Equity Shares of Rs 10/- each by its Initial Public Offering by raising funds aggregating to Rs 12 Crore on June 7, 2023. At present, Company is engaged in domestic business of manufacturing Pharmaceuticals products and the Manufacturing Unit is located in Roorkee, in the State of Uttarakhand. In order to maintain competitiveness and to further the cause of Healthcare, Company has laid a R&D Foundation and state of the art Manufacturing Facility in Roorkee. The major products for manufacturing dosage forms consist of Oral Liquid (Syrups/Suspensions/Dry Powders (�eta & Non �eta-Lactam), Tablets & Capsules (�eta & Non �eta-Lactam) and External Preparations. Ointments along with similar products like Creams, Lotions, Gels or Pates are certain formulations primarily designed to be applied to the skin. Beta-Lactam are a group of medicines that are used to treat infections caused by some germs (bacteria and certain parasites). They do not work against infections that are caused by viruses - for example, the common cold or flu. There are various type of dosages in this group like Tablets, Capsules, Injection and Dry Syrups for Oral Solution. Non-Beta-Lactam Tablets & Capsule Products group medicines are generally used for general diseases like Cold, Flu, Fever, Anti-gastrological, Antimalaria, and other viral diseases. Antibiotics are normally only prescribed for serious bacterial infections, as many infections get better independently.
Vilin Bio Med share price as on 17 Dec 2025 is Rs. 19.85. Over the past 6 months, the Vilin Bio Med share price has decreased by 31.43% and in the last one year, it has decreased by 0.75%. The 52-week low for Vilin Bio Med share price was Rs. 16.25 and 52-week high was Rs. 32.5.
78871
VILINBIO
INE0L4V01013
Aug
Vilin Bio Med Ltd FAQs
You can buy Vilin Bio Med Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Vilin Bio Med Ltd Share.
Company share prices and volatile and keep changing according to the market conditions. As of Dec 17, 2025 01:23 PM the closing price of Vilin Bio Med Ltd was Rs.19.85.
The latest PE ratio of Vilin Bio Med Ltd as of Dec 17, 2025 01:23 PM is 118.44
The latest PB ratio of Vilin Bio Med Ltd as of Dec 17, 2025 01:23 PM is 1.15
The 52-week high of Vilin Bio Med Ltd share price is Rs. 32.50 while the 52-week low is Rs. 16.25
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of Dec 17, 2025 01:23 PM, the market cap of Vilin Bio Med Ltd stood at Rs. 27.69 Cr.
Market Outlook
View allWe appreciate your patience. Your content is on the way.